Status:

COMPLETED

Bronchoscopic Lung Volume Reduction Using Blood

Lead Sponsor:

Chelsea and Westminster NHS Foundation Trust

Conditions:

Emphysema

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

The prupose of this study is to determine the feasibility, effectiveness, and safety of injecting blood into the airways to cause lung volume reduction in people with severe emphysema.

Detailed Description

This will be a randomised, double blind, placebo controlled trial where the response in patients treated with blood LVR will be compared to patients treated with placebo (control group). Analysis will...

Eligibility Criteria

Inclusion

  • Age 18-80 years
  • Moderate to severe airflow obstruction FEV1 \<50% Predicted
  • Severe dyspnoea - mMRC ≥2
  • Hyperinflation - total lung capacity (TLC) ≥100% predicted, RV ≥150% predicted
  • Optimum COPD treatment for at least 6 weeks
  • No COPD exacerbation for at least 6 weeks
  • Less than 3 admissions for exacerbation in the preceding 12 months

Exclusion

  • Patient unable to provide informed consent
  • Total lung CO uptake (TLCO) \<15% predicted and FEV1 \<15% predicted
  • pO2 on air \<6.0kPa
  • pCO2 on air \>8.0kPa
  • Other major medical illness, e.g. lung cancer that will limit participation
  • Clinically significant bronchiectasis
  • Large bulla - more than 1/3 of hemithorax volume (i.e. where bullectomy would be more suitable) on CT scan
  • Arrhythmia or cardiovascular disease that poses a risk during procedure
  • Prednisolone dose greater than 10mg a day
  • Prior LVRS or lobectomy
  • Lung nodule requiring surgery
  • Female of childbearing age with positive pregnancy test
  • Subject participated in a research study of investigational drug or device in prior 30 days
  • Subject taking clopidogrel, warfarin, or other anticoagulants and unable to abstain for 5 days pre-procedure

Key Trial Info

Start Date :

November 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2013

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT01528267

Start Date

November 1 2009

End Date

March 1 2013

Last Update

December 20 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chelsea and Westminster NHS Foundation Trust

London, United Kingdom

Bronchoscopic Lung Volume Reduction Using Blood | DecenTrialz